Biodelivery Sciences International

-0.01 (-0.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)407.21M
Current PE12.02
Forward PE 15.88
2yr Forward PE 9.6
See more stats
Estimates Current Quarter
Revenue$43.46 Million
Adjusted EPS$0.06
See more estimates
10-Day MA$4.05
50-Day MA$3.87
200-Day MA$3.80
See more pivots

Biodelivery Sciences International Stock, NASDAQ:BDSI

4131 Parklake Avenue, Suite 225, Raleigh, North Carolina 27612
United States of America
Phone: +1.919.582.9050
Number of Employees: 176


BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.